Nexagon® Low Dose

DRUG2 trials

Sponsors

OcuNexus Therapeutics, Inc.

Conditions

Diabetic Foot UlcersVenous Leg Ulcers

Phase 2

A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers

CompletedNCT01199588

OcuNexus Therapeutics, Inc.Venous Leg Ulcers

Start: 2011-05-31End: 2013-03-31Target: 300Updated: 2014-05-01

A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)

CompletedNCT01490879

OcuNexus Therapeutics, Inc.Diabetic Foot Ulcers

Start: 2012-07-31End: 2014-04-30Updated: 2014-05-01